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No pheochromocytomas or parathyroid disease have
been recognized in this family to date. However, one
individual with a positive stimulated calcitonin test has a
marginal increase in urinary catecholamine metabolites
and was hypercalcemic on one occasion.

We
have i d e n t i f i e d f i v e k i n d r e d s w i t h f a m i l i a l
medullary carcinoma of the thyroid (MTC) or multiple
endocrine neoplasia syndromes type 2 (MEN-2) in New
Hampshire and Vermont during the past five years.
These families have been f o l l o w e d by periodic calcitonin testing after stimulation by calcium and pentagastrin (1). Affected individuals have been treated by
total thyroidectomy.

A 50-year-old member of the kindred was treated successfully w i t h radioiodine for Graves' disease 15 years
ago and is scheduled for total thyroidectomy because of
elevated calcitonin levels. Radioiodine treatment has
been used to remove thyroid remnants in patients w h o
have had total thyroidectomies for MTC (5); the reasoning is that any remaining C-cells in the patient w o u l d be
destroyed by radiation f r o m adjacent follicular cells. In
this patient, radioiodine treatment was not effective in
destroying all C-cells.

Brattleboro Kindred
Eight individuals with MTC and three with C-cell hyperplasia alone have undergone total thyroidectomy within
the past five years at ages ranging f r o m 19 to 72 years
(Figure). Remarkably, no individual has as yet suffered
any apparent ill eftect f r o m the t u m o r even though
regional lymph node metastases were present in t w o
patients.

Other Kindreds

The possibility of delayed or incomplete penetrance of
the MTC gene is suggested by the finding of positive
stimulated calcitonin tests in t w o young men (IV-45 and
IV-91); their mothers, the apparent obligate carriers of
the MTC gene, have each had at least t w o normal stimulated calcitonin tests at ages 41 and 39, respectively.
These findings are unexpected since the MTC gene is
believed to be fully penetrant at age 40 (2). Studies of
katacalcin (3) and calcitonin gene-related peptide (4)
secretion are currently underway to obtain further information about C-cell mass in these patients.

Three additional families are u n d e r s t u d y ; one man w i t h
MTC whose mother had p h e o c h r o m o c y t o m a , and t w o
because the propositi have had C-cell hyperplasia o n
review of their thyroid gland histology.
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To date, no evidence of pheochromocytoma has been
found in this family. O n e 32-year-old man, w h o has not
had a stimulated calcitonin test, had a parathyroid
adenoma removed at age 18, but no other cases of
hypercalcemia have been seen.
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Four individuals with MTC, aged 38 to 70, have had
thyroidectomies in the past two years. A fifth individual,
now deceased, had metastatic MTC f o u n d by lymph
node biopsy at age 67. An additional six individuals have
had positive stimulated calcitonin tests.
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B Negative stimulated calcitonin test
* Parathyroid adenoma

• Confirmed MCT or C-cell hyperplasio
9 Positive stimuloted calcitonin test
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Brattleboro Kindred
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